BMY • NYSE
Bristol-Myers Squibb Co
$64.89
After Hours:
$64.32
(0.88%)-0.57
Closed: Jan 18, 4:24:17 PM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$64.93
Day range
$63.81 - $65.03
Year range
$53.22 - $69.75
Market cap
144.03B USD
Volume
13.19M
P/E ratio
-
Dividend yield
3.33%
Primary exchange
NYSE
CDP Climate Change Score
A-
In the news
Financial performance
(USD)Sep 2021Year/year change
Revenue
11.62B10.28%
Net income
1.55B-17.41%
Diluted EPS0.69-15.85%
Net profit margin13.30%-25.11%
Operating income2.67B30.75%
Net change in cash2.48B594.42%
Cash on hand--
Cost of revenue2.19B7.39%
About
Bristol Myers Squibb is an American multinational pharmaceutical company, headquartered in New York City. BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had total revenue of $39.3 billion. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders. BMS's primary R&D sites are located in Lawrence, New Jersey, Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Boudry in Switzerland, with other sites in Devens and Cambridge, Massachusetts, East Syracuse, New York, Braine-l'Alleud, Belgium, Tokyo, Japan, Bangalore, India, and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut. Wikipedia
Founded
1887
Website
Employees
30,250
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more